AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
Active exploits, nation-state campaigns, fresh arrests, and critical CVEs — this week's cybersecurity recap has it all.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果